RT Journal Article
SR Electronic
T1 A retrospective case - control study for assessing the risk factors for development of Diabetic Kidney Disease among people with Type 2 Diabetes in Tamil Nadu and Puducherry
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.12.02.22283018
DO 10.1101/2022.12.02.22283018
A1 Saji, Sneha
A1 Suresh, Srividya
A1 MC, Deepak
A1 Krishnaswamy, Sampath Kumar
A1 Asirvatham, Arthur Joseph
A1 Kumar, Manoj
A1 George, Melvin
A1 Kumaraswamy, Subramaniyan
A1 Krishnamoorthy, Narayanan
A1 Raman, Gopinath
A1 Kannan, Arun
A1 Mehta, Ratnesh Bhai
YR 2022
UL http://medrxiv.org/content/early/2022/12/08/2022.12.02.22283018.abstract
AB Objective To understand the associated risk factors in the progression of Diabetic Kidney Disease among the Type 2 Diabetes individuals living in the state of Tamil Nadu and Puducherry.Research design and methods Clinical and socio-demographic data was collected, digitized, and analyzed for 482 participants diagnosed either with Diabetic Kidney Disease (DKD) or Type 2 Diabetes (T2D). The study was analyzed by using descriptive statistical analysis SAS version 9.4.Results Out of 482 participants, 422 fulfilled the eligibility criteria. Gender, age, T2D duration, and comorbidity are the major risk factors that are found to be associated with DKD in population understudy. We also found inclination towards usage of insulin among DKD participants rather than oral diabetic medications. Metformin (Biguanides) was the most used oral diabetic medication among the T2D participants followed by DPP-4 inhibitors and Sulphonylureas.Conclusion Together, these data describe the risk pattern among participants diagnosed with DKD at regional level that is integral in early and proper management of the disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of Hindu Mission Hospital, Chennai gave ethical approval for this work. Ethics committee of Madras Medical Mission Hospital, Chennai gave ethical approval for this work. Ethics committee of SRM Medical College Hospital & Research Centre, Chennai gave ethical approval for this work. Ethics committee of Arthur Asirvatham Hospital gave ethical approval for this work. Ethics committee of Meenakshi Mission Hospital & Research Centre gave ethical approval for this work. Ethics Committee of Jehangir Clinical Developmental Centre (JCDC) Ethics Committee pvt. ltd. gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors